Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lizardo MM"'
Autor:
Lizardo MM; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Hughes C; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Huang YZ; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Shyp T; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Delaidelli A; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Zhang HF; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Shaool SS; University of Victoria, Victoria, British Columbia, Canada., Renner AF; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Burwag F; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada., Sayles LC; Helen Diller Family Comprehensive Cancer Program, University of California San Francisco, San Francisco, California., Lee AG; Helen Diller Family Comprehensive Cancer Program, University of California San Francisco, San Francisco, California., Sweet-Cordero A; Helen Diller Family Comprehensive Cancer Program, University of California San Francisco, San Francisco, California., Sorensen PH; Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4464-4481.
Autor:
Mooney B; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Negri GL; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Shyp T; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Delaidelli A; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Zhang HF; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Spencer Miko SE; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Weiner AK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Radaoui AB; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Shraim R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Lizardo MM; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Hughes CS; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Li A; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., El-Naggar AM; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Rouleau M; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Li W; Division of Infectious Diseases, Department of Medicine, Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania., Dimitrov DS; Division of Infectious Diseases, Department of Medicine, Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania., Kurmasheva RT; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas., Houghton PJ; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas., Diskin SJ; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Morin GB; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Sorensen PH; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 01; Vol. 30 (5), pp. 1022-1037.
Autor:
Turgu B; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., El-Naggar A; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Pathology, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt., Kogler M; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Tortola L; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Zhang HF; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada., Hassan M; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada., Lizardo MM; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada., Kung SH; Department of Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Lam W; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; Helmholtz Centre for Infection Research, Braunschweig, Germany., Sorensen PH; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
EMBO reports [EMBO Rep] 2023 Dec 06; Vol. 24 (12), pp. e56815. Date of Electronic Publication: 2023 Oct 17.
Autor:
Ramos L; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Truong S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Zhai B; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Joshi J; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Ghaidi F; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Lizardo MM; BC Cancer Agency, Vancouver, British Columbia, Canada., Shyp T; BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Kung SHY; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Rezakhanlou AM; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Oo HZ; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Adomat H; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Le Bihan S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Collins C; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Bacha J; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Brown D; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Langlands J; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Shen W; Rakovina Therapeutics, Vancouver, British Columbia, Canada., Lallous N; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Sorensen PH; BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Rakovina Therapeutics, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3541-3553.
Autor:
Zhang HF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Delaidelli A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Javed S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Turgu B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Morrison T; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Hughes CS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Yang X; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Pachva M; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Lizardo MM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Singh G; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Hoffmann J; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Huang YZ; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Patel K; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Shraim R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Kung SHY; Vancouver Prostate Centre, Vancouver, BC V6H3Z6, Canada., Morin GB; Canada's Michael Smith Genome Sciences Centre, Vancouver, BC V5Z4S6, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T1Z4, Canada., Aparicio S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada., Martinez D; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Bosse KR; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Williams KC; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Sorensen PH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Publikováno v:
Science advances [Sci Adv] 2023 Aug 25; Vol. 9 (34), pp. eadg6693. Date of Electronic Publication: 2023 Aug 23.
Autor:
Zhang HF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Hughes CS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Li W; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania., He JZ; Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, China., Surdez D; INSERM U830, Equipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.; Balgrist University Hospital, University of Zurich, Zurich, Switzerland., El-Naggar AM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Cheng H; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.; Modelling and translation Laboratory, Xinxiang Medical University, Xinxiang, Henan, China., Prudova A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Delaidelli A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Negri GL; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Li X; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Ørum-Madsen MS; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Lizardo MM; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Oo HZ; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Colborne S; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Shyp T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Scopim-Ribeiro R; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Hammond CA; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Dhez AC; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Langman S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lim JKM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Kung SHY; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Li A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Steino A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Daugaard M; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Parker SJ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Geltink RIK; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Orentas RJ; Seattle Children's Research Institute, Seattle, Washington.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Xu LY; Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, China., Morin GB; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Delattre O; INSERM U830, Equipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France., Dimitrov DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania., Sorensen PH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. psor@mail.ubc.ca.; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Nov; Vol. 11 (11), pp. 2884-2903. Date of Electronic Publication: 2021 May 21.
Autor:
Scopim-Ribeiro R; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada., Lizardo MM; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada., Zhang HF; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada., Dhez AC; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada., Hughes CS; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada., Sorensen PH; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Mar 22; Vol. 11, pp. 645757. Date of Electronic Publication: 2021 Mar 22 (Print Publication: 2021).
Autor:
Fan TM; Comparative Oncology Research Laboratory, Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States., Roberts RD; Center for Childhood Cancer and Blood Disorders, Abigail Wexner Research Institute at Nationwide Children's Hospital, The James Comprehensive Cancer Center at The Ohio State University, Columbus, OH, United States., Lizardo MM; Poul Sorensen Laboratory, Department of Molecular Oncology, BC Cancer, Part of the Provincial Health Services Authority in British Columbia, Vancouver, BC, Canada.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 Jan 31; Vol. 10, pp. 13. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).
Autor:
Roberts RD; Center for Childhood Cancer, Nationwide Children's Hospital, The Ohio State University James Comprehensive Cancer Center, Columbus, Ohio., Lizardo MM; Department of Molecular Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, British Columbia, Canada., Reed DR; Sarcoma Department, Chemical Biology and Molecular Medicine Program and Adolescent and Young Adult Oncology Program, Moffitt Cancer Center, Tampa, Florida., Hingorani P; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona., Glover J; Children's Cancer and Blood Disorders Program, Randall Children's Hospital, Portland, Oregon., Allen-Rhoades W; Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas.; Texas Children's Hospital Cancer and Hematology Centers, Houston, Texas., Fan T; Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign, Illinois., Khanna C; Ethos Vet Health, Woburn, Massachusetts.; Ethos Discovery (501c3), Washington, DC., Sweet-Cordero EA; Division of Hematology and Oncology, Department of Pediatrics, University of California San Francisco, San Francisco, California., Cash T; Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Bishop MW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Hegde M; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Sertil AR; Department of Basic Medical Sciences, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona., Koelsche C; Department of General Pathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany., Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Malkin D; Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Pediatrics, Division of Hematology/Oncology, University of Toronto, Toronto, Ontario, Canada., Sorensen PH; Department of Molecular Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Meltzer PS; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Crompton BD; Dana-Farber Cancer Institute, Boston, and Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Publikováno v:
Cancer [Cancer] 2019 Oct 15; Vol. 125 (20), pp. 3514-3525. Date of Electronic Publication: 2019 Jul 29.
Autor:
Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, Dhillon G, Chee DR, Myers JT, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin BP, Huang AY, Meltzer PS, Helman LJ, Picci P, Versteeg HH, Stamatoyannopoulos JA, Khanna C, Scacheri PC
Publikováno v:
Nature medicine [Nat Med] 2018 Apr 10; Vol. 24 (4), pp. 525.